Christopher McCabe

9PUBLICATIONS
105CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Ethical use of new technologyPreventative health careEconomic models and forecastingInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 09, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Fiona Collinson, Kara-Louise Royle, Jayne Swain

|Sep 27, 2023
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.

Victoria Charlton, Michael DiStefano, Polly Mitchell

|Mar 24, 2023
Vaccine rollout strategies: The case for vaccinating essential workers early.

Nicola Mulberry, Paul Tupper, Erin Kirwin

|Jan 19, 2021
NICE's Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests.

James F O'Mahony, Mike Paulden, Chris McCabe

|Nov 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier.

Christopher McCabe, Giovanni Tramonti, Andrew Sutton

|Sep 04, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.

Helena Earl, Louise Hiller, Anne-Laure Vallier

Pageof 2